Phase 2 Neuroendocrine Tumor Grade 2 Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
CapTemY90 for Grade 2/3 NET Liver Metastases
Neuroendocrine TumorsNeuroendocrine Tumor Grade 2
Abramson Cancer Center at Penn Medicine70 enrolled4 locationsNCT04339036
Recruiting
Phase 2
177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry
Neuroendocrine TumorsNeuroendocrine Tumor Grade 1Neuroendocrine Tumor Grade 2
University of Iowa120 enrolled1 locationNCT06395402
Recruiting
Phase 2Phase 3
Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial
Neuroendocrine NeoplasmNeuroendocrine TumorsNeuroendocrine Tumor Grade 1+1 more
The Netherlands Cancer Institute39 enrolled1 locationNCT06855095
Recruiting
Phase 2
Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors
Neuroendocrine TumorsProgressionNeuroendocrine Tumor of Pancreas+4 more
AC Camargo Cancer Center100 enrolled2 locationsNCT06472388